Market Capitalization: Amgen Corporation (AMGN)

Amgen Inc. (AMGN) maintains its status as a biotech pioneer, countering intense pressure from biosimilars through colossal R&D expenditures. A team of leading chemists and biologists drives innovation, supported by top-tier laboratories and premium bonuses. This chart on the GURU.Markets platform reflects an asset value of 253.54, underscoring the scale of the business. Surplus cash flow ensures the confident repayment of debts.

AMGN Amgen: Market Capitalization in the range 07/04/2022 - 11/12/2026

Comprehensive metric breakdowns and analytics for Amgen Inc (AMGN)

- market price and analyst price targets:

Price Chart Amgen|AMGN - Consensus Target

- company stock exchange capitalization indicators:

Market Capitalization Amgen Inc|AMGN - Full Takeover Company Value

- issuer book value statistics:

Net Assets per Single Share Amgen|AMGN - Accounting Capitalization|Market Value to Book Value Ratio amgen.com|AMGN - Total Asset Value of Company

- debt and liquidity details:

- business earnings and investment ratios data:

AMGN - Net Profit|Future Profit Amgen Inc.|AMGN - Company Value to Net Income|Forward P/E Multiple Amgen Corporation|AMGN - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Amgen Inc|AMGN - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Amgen|AMGN - Earnings per share for the last twelve months|Quarterly EPS earnings growth amgen.com|AMGN - Earnings per share growth this year|Earnings growth forecast for next year Amgen Inc.

Fundamental company analysis:AMGN (Amgen)

The stability of Amgen Inc. (AMGN) is underpinned by a portfolio of indispensable biologics whose sales remain insulated from economic cycles. By analyzing the company's market capitalization chart, calculated as the product of the current share price and the total number of shares, an investor assesses the business's market value, where price resilience during crises confirms the asset's fundamental strength and determines its potential for future returns.

Key competitors